IHC staining of CD44 in tumors from mice co-injected with tumor cells and shNC or shSpry2 fibroblasts showed enhanced CD44 expression in shSpry2 groups (Additional file 4: Figure S3A). This evidence concerns the gene CD44 and neoplasm.